<DOC>
	<DOCNO>NCT01968941</DOCNO>
	<brief_summary>A multi-centre randomized control open-label trial medically inoperable patient biopsy-proven early stage non-small cell lung cancer ( NSCLC ) . Eligible consent patient randomly allocate receive stereotactic body radiotherapy ( SBRT ) conventional radiotherapy ( CRT ) 2:1 ratio . Radiotherapy administer soon possible follow randomization subject follow 5 year post-randomization cancer recurrence , toxicity survival . The primary outcome local control ( LC ) . The trial conduct 16-20 clinical centre throughout Canada .</brief_summary>
	<brief_title>Stereotactic Body Radiotherapy Versus Conventional Radiotherapy Medically-Inoperable Non-Small Lung Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . T1/T2a N0 M0 NSCLC , either : ( ) histological confirmation ( squamous cell , adenocarcinoma , large cell carcinoma , specify ) CT thorax and/or PETCT evidence , ( b ) suspicious grow nodule serial CT imaging , malignant PET Fluorodeoxyglucose ( FDG ) avidity , biopsy would extremely risky . 2 . Deemed medically inoperable ( review thoracic surgeon define surgically resectable , underlying physiological medical problem [ e.g . chronic obstructive pulmonary disease ( COPD ) , heart disease ] , surgery contraindicate ) Radiotherapy preferred patient due high operable risk . 1 . Less 18 year age . 2 . Eastern Cooperative Oncology Group ( ECOG ) performance status 3 high . 3 . Prior invasive malignancy within past 5 year ( exclude nonmelanomatous skin cancer ) . 4 . History ataxia telangiectasia . 5 . Previous radiotherapy ( RT ) vicinity tumour , significant overlap could occur . 6 . Diagnosis idiopathic pulmonary fibrosis . 7 . Planned anticancer therapy ( chemotherapy , biological target therapy ) . 8 . Female , currently pregnant lactating . 9 . Geographic inaccessibility followup . 10 . Unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>stereotactic body radiotherapy</keyword>
	<keyword>conventional radiotherapy</keyword>
	<keyword>inoperable patient</keyword>
	<keyword>local control</keyword>
	<keyword>cancer recurrence</keyword>
	<keyword>toxicity</keyword>
	<keyword>survival</keyword>
</DOC>